Patents for C12R 1 - Micro-organisms (92,025) |
---|
08/10/2000 | WO2000046388A1 Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth |
08/10/2000 | WO2000046353A1 Sebocytes, sebocyte cell lines and applications thereof |
08/10/2000 | WO2000046351A2 Platform for the differentiation of cells |
08/10/2000 | WO2000046349A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
08/10/2000 | WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
08/10/2000 | WO2000046175A1 Microbial process for preparing pravastatin |
08/10/2000 | WO2000045840A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
08/10/2000 | WO2000045640A1 Pesticidal use of a parasitic flagellate for eliminating or suppressing harmful algae blooms |
08/10/2000 | WO2000045633A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor |
08/10/2000 | WO2000010584A9 Method for detection of legionella bacteria employing purified antigen-specific antibodies |
08/10/2000 | DE19905069A1 Nucleinsäuremoleküle codierend Alternansucrase Nucleic acid molecules encoding alternansucrase |
08/10/2000 | DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses |
08/10/2000 | DE10003096A1 Kulturmedium zum Züchten von Lactobacillus Clearans und Verfahren zum Konservieren dieses Stamms Culture medium for the growth of Lactobacillus Clearans and method for preserving this strain |
08/10/2000 | CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
08/10/2000 | CA2360840A1 Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth |
08/10/2000 | CA2359821A1 Platform for the differentiation of cells |
08/10/2000 | CA2359469A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
08/09/2000 | EP1026262A2 Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof |
08/09/2000 | EP1026256A2 Method for the production of optically active cyanohydrins |
08/09/2000 | EP1026255A1 Process for preparing xylitol |
08/09/2000 | EP1026254A1 Process for preparing xylitol |
08/09/2000 | EP1026251A2 Transgenic animals expressing human P25 |
08/09/2000 | EP1026250A1 DNA-constructs of blood clotting factors and P-selectin |
08/09/2000 | EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
08/09/2000 | EP1026241A1 An improved method for preparing DNA from serum and plasma |
08/09/2000 | EP1026240A2 Generation and selection of recombinant varied binding proteins |
08/09/2000 | EP1026239A2 A new method for tapping the immunological repertoire |
08/09/2000 | EP1026238A2 Cloned glutamic acid decarboxylase |
08/09/2000 | EP1026235A1 Levodione reductase |
08/09/2000 | EP1026173A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
08/09/2000 | EP1025255A1 Method for preparing a substituted benzamide |
08/09/2000 | EP1025242A1 A method of inhibiting an immune response to a recombinant vector |
08/09/2000 | EP1025241A2 Multiply-substituted protease variants |
08/09/2000 | EP1025240A2 Multiply-substituted protease variants with altered net charge for use in detergents |
08/09/2000 | EP1025239A2 Multiply-substituted protease variants |
08/09/2000 | EP1025213A1 Epoxide hydrolase |
08/09/2000 | EP1025211A2 Hyaluronan synthase gene and uses thereof |
08/09/2000 | EP1025194A1 Bleaching compositions comprising multiply-substituted protease variants |
08/09/2000 | EP1025052A1 Method for reducing the effect of detergents upon germination and/or growth of microorganisms |
08/09/2000 | EP1024828A1 NOVEL pheS (BETA) |
08/09/2000 | EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
08/09/2000 | EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
08/09/2000 | EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
08/09/2000 | EP0568645B1 Mixed specificity fusion proteins |
08/09/2000 | EP0556171B1 Growth hormone antagonists |
08/09/2000 | CN1055314C Cloning and over expression of glucose-6-phosphate dehydrogenase fro leuconostoc dextranicus |
08/08/2000 | US6100446 Plant cell transformed with nucleotide sequences which code a degratory enzymatic protein; for pollution control |
08/08/2000 | US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals |
08/08/2000 | US6100376 A21, B30, modified insulin derivatives having an altered action profile |
08/08/2000 | US6100241 Nucleic acids encoding an immunogenic fragment of eimeria lactate dehydrogenase (ldh) which will react with antiserum raised against the ldh; preparing a vector vaccine against coccidiosis; administering to prevent coccidiosis in birds |
08/08/2000 | US6100235 Methods of treating immune and inflammatory response with IL-17 receptors |
08/08/2000 | US6100088 Viral vaccines |
08/08/2000 | US6100078 Purified DNA polymerase from bacillus stearothermophilus ATCC 12980 |
08/08/2000 | US6100076 Amino acid sequence of enzyme which glycosylates an epidermal growth factor domain of a polypeptide with an activated fucose moiety |
08/08/2000 | US6100073 Acid-stable and thermo-stable enzymes derived from sulfolobus species |
08/08/2000 | US6100065 Recombinant polypeptide particles with high immunogenicity; comprises portion of pre-s1 peptide and surface antigen peptide |
08/08/2000 | US6100057 Introducing regulatory sequences which link to endogenous heme biosynthetic enzymes or copies of nucleotide sequences encoding heme biosynthetic enzymes with linked regulatory sequences, culturing fungus, recovering secreted hemoprotein |
08/08/2000 | US6100053 Microbial transglutaminases, their production and use |
08/08/2000 | US6100052 Culturing strain of streptomyces clavuligerus in medium having initial soluble phosphate concentration of 150 and 600 mg/l, maintaining concentration between 20 and 150 mg/l by adding or removing soluble phosphate, isolating product |
08/08/2000 | US6099842 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin |
08/08/2000 | US6099840 Variant hbsag protein of fragment thereof displaying the antigenicity of hepatitis b virus surface antigen |
08/08/2000 | US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases |
08/08/2000 | US6099833 Method for inhibiting production of toxins from enteropathogenic escherichia coli, and butyric-acid bacteria and butyric-acid bacteria containing pharmaceuticals used in combination with antibiotics for the method |
08/08/2000 | CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle |
08/08/2000 | CA2216165C Ndf peptides |
08/08/2000 | CA2149764C Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom |
08/08/2000 | CA2125376C Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof |
08/08/2000 | CA2071907C Bcrf1 proteins as inhibitors of interferon-y |
08/08/2000 | CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function |
08/08/2000 | CA1341079C Large scale method for purification of high purity heparinase |
08/08/2000 | CA1341074C Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine |
08/08/2000 | CA1341073C Vectors and methods for expression of human protein c activity |
08/03/2000 | WO2000045176A2 METHOD OF IDENTIFYING N-TERMINAL proBNP |
08/03/2000 | WO2000044923A1 Biocatalytic synthesis of shikimic acid |
08/03/2000 | WO2000044899A1 Her-2/neu fusion proteins |
08/03/2000 | WO2000044883A1 Propagation of bovine coronavirus in chinese hamster ovary cells |
08/03/2000 | WO2000044772A2 Human serum albumin |
08/03/2000 | WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens |
08/03/2000 | WO2000044230A1 A method of controlling fungal pathogens, and agents useful for same |
08/03/2000 | WO2000037614A3 Variants of egiii-like cellulase and compositions thereof |
08/03/2000 | WO2000024878A3 Mutant luciferase having increased thermostability |
08/03/2000 | WO2000020609A3 Protective recombinant haemophilus influenzae high molecular weight proteins |
08/03/2000 | WO2000014240A3 Attenuated salmonella sp12 mutants as antigen carriers |
08/03/2000 | WO2000010593A9 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS |
08/03/2000 | WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
08/03/2000 | WO2000009669A9 Human mesencephalon cell lines and methods of use therefor |
08/03/2000 | WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them |
08/03/2000 | WO2000009018A9 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
08/03/2000 | WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof |
08/03/2000 | DE19903095A1 Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium Production of gamma-linolenic acid from protozoa of the genus Colpidium |
08/03/2000 | CA2361246A1 Identification of specific differentially expressed antigens |
08/03/2000 | CA2360600A1 A method of controlling fungal pathogens, and agents useful for same |
08/02/2000 | EP1024199A2 Recovery of gamma-linolenic acid from protozoa of the genus Colpidium |
08/02/2000 | EP1024197A2 Mesothelial cell gene therapy |
08/02/2000 | EP1024191A2 Production of chimeric antibodies from antibody segment repertoires and displayed on phage |
08/02/2000 | EP1024189A1 Novel antigenic class of avian reoviruses |
08/02/2000 | EP1024145A2 Novel azalides and methods of making same |
08/02/2000 | EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine |
08/02/2000 | EP1023462A1 ZOOGLOEAL AND $i(HYPHOMICROBIUM) SPP. NUCLEIC ACIDS |
08/02/2000 | EP1023438A1 Expression of starch-binding domain (sbd) |